| 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... European heart journal 39 (33), 3021-3104, 2018 | 15619 | 2018 |
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Scandinavian Simvastatin Survival Study Group The Lancet 344 (8934), 1383-1389, 1994 | 11447 | 1994 |
| Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis AB Rossebø, TR Pedersen, K Boman, P Brudi, JB Chambers, K Egstrup, ... New England journal of medicine 359 (13), 1343-1356, 2008 | 2148 | 2008 |
| Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in … K Wachtell, M Lehto, E Gerdts, MH Olsen, B Hornestam, B Dahlöf, H Ibsen, ... Journal of the American College of Cardiology 45 (5), 712-719, 2005 | 1285 | 2005 |
| Prognostic significance of left ventricular mass change during treatment of hypertension RB Devereux, K Wachtell, E Gerdts, K Boman, MS Nieminen, ... Jama 292 (19), 2350-2356, 2004 | 1175 | 2004 |
| Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes EUGenMed, Cardiovascular Clinical Study Group, V Regitz-Zagrosek, ... European heart journal 37 (1), 24-34, 2016 | 755 | 2016 |
| Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial RB Devereux, B Dahlöf, E Gerdts, K Boman, MS Nieminen, ... Circulation 110 (11), 1456-1462, 2004 | 738 | 2004 |
| Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults NH Phelps, RK Singleton, B Zhou, RA Heap, A Mishra, JE Bennett, ... The Lancet 403 (10431), 1027-1050, 2024 | 697 | 2024 |
| Sex differences in cardiometabolic disorders E Gerdts, V Regitz-Zagrosek Nature medicine 25 (11), 1657-1666, 2019 | 447 | 2019 |
| Outcome of patients with low-gradient “severe” aortic stenosis and preserved ejection fraction N Jander, J Minners, I Holme, E Gerdts, K Boman, P Brudi, JB Chambers, ... Circulation 123 (8), 887-895, 2011 | 446 | 2011 |
| Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis G Cioffi, P Faggiano, E Vizzardi, L Tarantini, D Cramariuc, E Gerdts, ... Heart 97 (4), 301-307, 2011 | 421 | 2011 |
| Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE … K Wachtell, B Hornestam, M Lehto, DJ Slotwiner, E Gerdts, MH Olsen, ... Journal of the American College of Cardiology 45 (5), 705-711, 2005 | 339 | 2005 |
| Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study E Gerdts, L Oikarinen, V Palmieri, JE Otterstad, K Wachtell, K Boman, ... Hypertension 39 (3), 739-743, 2002 | 326 | 2002 |
| 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of … JW McEvoy, CP McCarthy, RM Bruno, S Brouwers, MD Canavan, ... European heart journal 45 (38), 3912-4018, 2024 | 315 | 2024 |
| Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial E Gerdts, K Wachtell, P Omvik, JE Otterstad, L Oikarinen, K Boman, ... Hypertension 49 (2), 311-316, 2007 | 312 | 2007 |
| Low-flow aortic stenosis in asymptomatic patients: valvular–arterial impedance and systolic function from the SEAS substudy D Cramariuc, G Cioffi, ÅE Rieck, RB Devereux, EM Staal, S Ray, ... JACC: Cardiovascular Imaging 2 (4), 390-399, 2009 | 273 | 2009 |
| Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study K Wachtell, JN Bella, PR Liebson, E Gerdts, B Dahlöf, T Aalto, ... Hypertension 35 (1), 6-12, 2000 | 268 | 2000 |
| Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study K Wachtell, JN Bella, J Rokkedal, V Palmieri, V Papademetriou, ... Circulation 105 (9), 1071-1076, 2002 | 266 | 2002 |
| Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study) K Wachtell, G Smith, E Gerdts, B Dahlöf, MS Nieminen, V Papademetriou, ... The American journal of cardiology 85 (4), 466-472, 2000 | 259 | 2000 |
| Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study) E Gerdts, D Cramariuc, G De Simone, K Wachtell, B Dahlöf, RB Devereux European Journal of Echocardiography 9 (6), 809-815, 2008 | 235 | 2008 |
